Preventive and curative effects of etifoxine in a rat model of brain oedema

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 7, 2009, Pages 655-661

  Girard, Philippe ^a   Pansart, Yannick ^a   Gillardin, Jean Marie ^a  

^a Service de Pharmacologie   (France)

Author keywords

Brain oedema; Etifoxine; Neuroprotection; Neurotoxicant; Triethyltin

Indexed keywords

CHLORIDE; ETIFOXINE; NEUROPROTECTIVE AGENT; NEUROSTEROID; SODIUM; TRIETHYLTIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN EDEMA; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; GABAERGIC TRANSMISSION; LOCOMOTION; MALE; MORTALITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; RAT; STEROIDOGENESIS; TREATMENT DURATION; TREATMENT RESPONSE; WISTAR RAT;

ANIMALS; BRAIN EDEMA; DISEASE MODELS, ANIMAL; MALE; OXAZINES; RATS; RATS, WISTAR;

EID: 67650751670     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05127.x     Document Type: Article

References (45)

1. Okuyama S, Karasawa Y, Shiratsuchi A, Araki H, Aihara H. Protective effects of minaprine on the cerebrum of rodents. Res. Commun. Chem. Pathol. Pharmacol. 1988 60 : 381 95.
2. Myers KM, Fiskum G, Liu Y, Simmens SJ, Bredesen DE, Murphy AN. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability. J. Neurochem. 1995 65 : 2432 40.
3. Rabinstein AA. Treatment of cerebral edema. Neurologist 2006 12 : 59 73.
4. Costa C, Leone G, Saulle E, Pisani F, Bernardi G, Calabresi P. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. Stroke 2004 35 : 596 600. (Pubitemid 38174456)
5. Green AR, Hainsworth AH, Jackson DM. GABA potentiation: A logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology 2000 39 : 1483 94.
6. Kiewert C, Kumar V, Hildmann O et al. Role of GABAergic antagonism in the neuroprotective effects of bilobalide. Brain Res. 2007 1128 : 70 8.
7. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur. J. Endocrinol. 2001 145 : 669 79.
8. Wojtal K, Trojnar MK, Czuczwar SJ. Endogenous neuroprotective factors: Neurosteroids. Pharmacol. Rep. 2006 58 : 335 40.
9. Roof RL, Duvdevani R, Braswell L, Stein DG. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 1994 129 : 64 9.
10. Roof RL, Duvdevani R, Heyburn JW, Stein DG. Progesterone rapidly decreases brain edema: Treatment delayed up to 24 hours is still effective. Exp. Neurol. 1996 138 : 246 51.
11. Shear DA, Galani R, Hoffman SW, Stein DG. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp. Neurol. 2002 178 : 59 67. (Pubitemid 35425609)
12. Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr. Rehabil. 2003 6 : 13 22. (Pubitemid 36626716)
13. Wright DW, Bauer ME, Hoffman SW, Stein DG. Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J. Neurotrauma 2001 18 : 901 9.
14. Nguyen N, Fakra E, Pradel V et al. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: A double-blind controlled study in general practice. Hum. Psychopharmacol. 2006 21 : 139 49.
15. Servant D, Graziani PL, Moyse D, Parquet PJ. [Treatment of adjustment disorder with anxiety: Efficacy and tolerance of etifoxine in a double-blind controlled study]. Encephale 1998 24 : 569 74 (in French).
16. Verleye M, Schlichter R, Gillardin JM. Interactions of etifoxine with the chloride channel coupled to the GABA(A) receptor complex. Neuroreport 1999 10 : 3207 10.
17. Verleye M, Pansart Y, Gillardin J. Effects of etifoxine on ligand binding to GABA(A) receptors in rodents. Neurosci. Res. 2002 44 : 167 72.
18. Schlichter R, Rybalchenko V, Poisbeau P, Verleye M, Gillardin J. Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine. Neuropharmacology 2000 39 : 1523 35.
19. Verleye M, Schlichter R, Neliat G, Pansart Y, Gillardin JM. Functional modulation of gamma-aminobutyric acid(A) receptors by etifoxine and allopregnanolone in rodents. Neurosci. Lett. 2001 301 : 191 4.
20. Verleye M, Akwa Y, Liere P et al. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol. Biochem. Behav. 2005 82 : 712 20.
21. Bentue-Ferrer D, Reymann JM, Van den DJ, Allain H, Bagot H. Effect of triethyltin chloride on the central aminergic neurotransmitters and their metabolites: Relationship with pathophysiology of aging. Exp. Aging Res. 1985 11 : 137 41.
22. Linee P, Quiniou MJ, Godin C, Le Polles JB. [Cerebral edema in rats induced by triethyltin. Value and limitations as study method of cerebral antiedema drugs]. Ann. Pharm. Fr. 1984 42 : 431 42 (in French).
23. Ginsberg MD. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 2008 55 : 363 89.
24. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983 16 : 109 10.
25. Borzeix MG, Cahn J. Cerebral antioedematous effect of Teproside and of some vincamine derivatives. Int. J. Clin. Pharmacol. Res. 1984 4 : 259 61.
26. Girard P, Verniers D, Pansart Y, Gillardin JM. Efficacy of moclobemide in a rat model of neurotoxicant-induced edema. Can. J. Physiol. Pharmacol. 2007 85 : 556 61.
27. Otani M, Chatterjee SS, Gabard B, Kreutzberg GW. Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema. Acta Neuropathol. 1986 69 : 54 65. (Pubitemid 16146251)
28. McMillan DE, Wenger GR. Neurobehavioral toxicology of trialkyltins. Pharmacol. Rev. 1985 37 : 365 79.
29. Yanagisawa K, Ishigro H, Kaneko K, Miyatake T. Acetazolamide inhibits the recovery from triethyltin intoxication: Putative role of carbonic anhydrase in dehydration of central myelin. Neurochem. Res. 1990 15 : 483 6.
30. Brody TM, Moore KE. Biochemical aspects of triethyltin toxicity. Fed. Proc. 1962 21 : 1103 6.
31. Brand A, Leibfritz D, Wolburg H, Richter-Landsberg C. Interactions of triethyltin-chloride (TET) with the energy metabolism of cultured rat brain astrocytes: Studies by multinuclear magnetic resonance spectroscopy. Neurochem. Res. 1997 22 : 123 31.
32. 3H]aminobutyric acid uptake by organotin compounds in vitro. Toxicol. Appl. Pharmacol. 1985 79 : 471 9.
33. Mailman RB, Krigman MR, Frye GD, Hanin I. Effects of postnatal trimethyltin or triethyltin treatment on CNS catecholamine, GABA, and acetylcholine systems in the rat. J. Neurochem. 1983 40 : 1423 9.
34. A receptor function. Trends Pharmacol. Sci. 1995 16 : 295 303.
35. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: Biological role in steroidogenic cell function. Endocr. Rev. 1993 14 : 222 40.
36. Vanlandingham JW, Cutler SM, Virmani S et al. The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury. Neuropharmacology 2006 51 : 1078 85.
37. Thomas AJ, Nockels RP, Pan HQ, Shaffrey CI, Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 1999 24 : 2134 8.
38. Jiang N, Chopp M, Stein D, Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 1996 735 : 101 7.
39. Schumacher M, Guennoun R, Robert F et al. Local synthesis and dual actions of progesterone in the nervous system: Neuroprotection and myelination. Growth Horm. IGF Res. 2004 14 (Suppl. A S18 33.
40. Ghoumari AM, Ibanez C, El Etr M et al. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 2003 86 : 848 59.
41. Kruse HJ, Kuch H. Etifoxine: Evaluation of its anticonvulsivant profile in mice in comparison with sodium valproate, phenytoin and clobazam. Arzneimittelforschung 1985 35 : 133 5.
42. Demougeot C, Van Hoecke M, Bertrand N et al. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2′-dipyridyl in the rat photothrombotic ischemic stroke model. J. Pharmacol. Exp. Ther. 2004 311 : 1080 7.
43. Lang-Lazdunski L, Blondeau N, Jarretou G, Lazdunski M, Heurteaux C. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J. Vasc. Surg. 2003 38 : 564 75.
44. Nakajima H, Kakui N, Ohkuma K, Ishikawa M, Hasegawa T. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8- tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: Pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. J. Pharmacol. Exp. Ther. 2005 312 : 472 81.
45. Cristofol RM, Gasso S, Vilchez D, Pertusa M, Rodriguez-Farre E, Sanfeliu C. Neurotoxic effects of trimethyltin and triethyltin on human fetal neuron and astrocyte cultures: A comparative study with rat neuronal cultures and human cell lines. Toxicol. Lett. 2004 152 : 35 46. (Pubitemid 39030785)